U.S. Building Stock News

Molson Coors Beverage (TAP) is back in focus after the company named Will Meijer as president of Canada sales. This leadership change could reshape how it approaches one of its key markets. See our latest analysis for Molson Coors Beverage. Despite the leadership change drawing fresh attention, Molson Coors Beverage’s recent share price performance has been weaker, with a 30 day share price return of a 12.39% decline and a 1 year total shareholder return of a 26.67% loss, suggesting momentum...

On March 19, 2026, Goldman Sachs analyst George Tong commented that Homes.com traffic had moderated while Apartments.com usage remained stronger, and CoStar Group addressed investor concerns by emphasizing a shift to product-based reporting and continued detailed disclosures on Homes.com performance. This combination of softer Homes.com engagement and increased reporting transparency has sharpened investor focus on how CoStar’s residential strategy and segment-level data could influence...

In late March 2026, iRhythm Holdings used the ACC.26 meeting in New Orleans to unveil new large-scale real‑world data showing its Zio ambulatory ECG service frequently detects clinically actionable arrhythmias in cardiometabolic and chronic kidney disease patients, while also launching the iRhythm Academy clinician education platform and expanding its AI collaborations. A distinctive takeaway is how iRhythm is pairing a very large ECG dataset with predictive AI and targeted clinician...

Packaging Corporation of America: Recent Moves In Context Packaging Corporation of America (PKG) has drawn attention after a month return of about a 10% decline, even as its past 3 months performance is slightly positive, prompting investors to reassess the containerboard producer. See our latest analysis for Packaging Corporation of America. At a share price of US$209.04, PKG has seen a 1-month share price return of about a 10% decline, even as the 1-year total shareholder return of 8.16%...

Williams Companies (WMB) is back on investors’ radar after recent share price moves, with the stock showing mixed returns over the past week and month while remaining meaningfully higher over the past 3 months and year. See our latest analysis for Williams Companies. Short term momentum has cooled, with a 1 month share price return of a 3.01% decline following prior gains that left the 3 month share price return at 20.46% and the 1 year total shareholder return at 25.24%. This may hint at...

Without a specific news catalyst, Incyte (INCY) has attracted attention after a period where the share price shows a one-month return of about negative 11% and a past three-month return around negative 9%. See our latest analysis for Incyte. At a share price of $90.33, the recent 1 month share price return of around an 11% decline continues the softer trend seen over 3 months and year to date, even though the 1 year total shareholder return of about 49% and 3 year total shareholder return of...

Guardian Pharmacy Services, Inc. recently completed a follow-on equity offering of 6,000,000 Class A common shares at US$31.00 each, raising about US$186,000,000, and its board also formed a Nominating and Governance Committee chaired by independent director Mary Sue Patchett. This combination of fresh equity capital and enhanced board governance could shape how Guardian funds future growth while reinforcing oversight of board appointments and corporate policies. We will now examine how...

Ermenegildo Zegna (ZGN) is in focus after reporting full year 2025 results, with sales of €1,916.95 million, net income of €98.58 million, and a proposed €0.12 per share dividend, pending shareholder approval. See our latest analysis for Ermenegildo Zegna. The earnings release and proposed dividend come after a mixed period for the stock, with a 12.6% decline in the 30 day share price return and a 35.2% gain in the 1 year total shareholder return, suggesting longer term holders have fared...

If you are wondering whether GE Vernova's current share price really matches its potential, you are not alone. Many investors are trying to work out what a fair value looks like for this stock. The share price recently closed at US$817.35, with returns of 20.3% year to date and 168.5% over the last year, alongside 7.4% and 6.4% declines across the past 7 and 30 days respectively. Recent moves have come as investors continue to react to GE Vernova's position within the broader capital goods...

In March 2026, Bio-Techne Corporation expanded its COMET spatial biology portfolio by introducing new SPYRE Focus Panels, SPYRE Amplification Kits using seqLA technology, and upgraded HORIZON Image Analysis Software to enhance automated, high-plex tissue analysis from assay design through interpretation. An interesting aspect is how the modular SPYRE antibody panels and amplification tools are designed to plug into existing lab workflows, potentially shortening optimization timelines while...

Index removal and shelf registration use draw fresh attention Brookfield Business Partners (BBU) recently dropped out of the S&P/TSX Income Trust Index, a change that can affect fund flows. The partnership has also fully used its 2023 shelf registration for limited partnership units. See our latest analysis for Brookfield Business Partners. Recent trading reflects that tension clearly, with a 1-month share price return of a 7.69% decline and a 90-day share price return of an 11.28% decline,...

If you are wondering whether Pfizer's current share price reflects its underlying value, you are not alone. This article is designed to help you frame that question clearly. Find out why Pfizer's 17.5% return over the last year is lagging behind its peers. Approach 1: Pfizer Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today’s dollars to estimate what the business might be worth right now. For...

If you are wondering whether CECO Environmental at around US$57 is still offering value or if most of the easy gains are already behind it, this breakdown is for you. The stock recently pulled back with an 8.1% decline over 7 days and a 5.7% decline over 30 days, while the 1 year return sits at 146.9% and the 3 year return is very large. Recent headlines have focused on CECO Environmental as an environmental solutions provider, highlighting how it is positioned around air pollution control,...

Lincoln Electric Holdings (LECO) has drawn attention after recent share price softness, with the stock down about 15% over the past month even as its 1 year total return is near 29%. See our latest analysis for Lincoln Electric Holdings. The recent 14.9% 1 month share price decline, alongside a softer 7 day share price return of 4.1% and a modest 1.9% 90 day share price gain, contrasts with Lincoln Electric Holdings' stronger 1 year total shareholder return of 28.8%. This suggests momentum...

Edgewell Personal Care (EPC) has filed a US$45.701 million shelf registration for up to 2,300,000 common shares tied to its Employee Stock Ownership Plan, raising fresh questions about potential dilution and capital allocation priorities. See our latest analysis for Edgewell Personal Care. At a share price of US$21.43, Edgewell Personal Care has seen a 9.84% 7 day share price return and a 25.03% 90 day share price return. However, the 1 year total shareholder return of 29.41% and 3 year total...

ZenaTech is focusing its efforts into building AI drones, combining Drone as a Service, SaaS, and AI as its key revenue drivers.

Why LyondellBasell Industries (LYB) is back on investors’ radar LyondellBasell Industries (LYB) has jumped into focus after tighter North American polyethylene inventories, moderating natural gas feedstock costs and stronger oxyfuels margins coincided with the company outperforming its recent cash improvement target. See our latest analysis for LyondellBasell Industries. That backdrop has coincided with sharp share price momentum, with a 7 day share price return of 15.27% and a 90 day share...

Earnings reaction puts Dole (DOLE) under closer investor scrutiny Dole (DOLE) recently reported quarterly revenue of US$2.37b, up 9.2% year on year and ahead of forecasts, but EBITDA and gross margins fell short of expectations, and the stock is down 10% since the release. See our latest analysis for Dole. At a share price of US$14.39, Dole’s recent 30 day share price return of 10.29% and 90 day share price return of 3.62% contrast with a 3 year total shareholder return of 27.32%. This...

In March 2026, Thermo Fisher Scientific announced a collaboration with SHL Medical to build an integrated U.S. hub in Ridgefield for sterile fill-finish, autoinjector assembly, and commercial packaging of patient-friendly injectable therapies, complementing its global sterile manufacturing network. This move deepens Thermo Fisher’s role as an end-to-end partner for pharma and biotech customers by linking drug manufacturing directly to finished self-injection devices in a single, scalable...

Sieve Capital’s public challenge to Americold Realty Trust (COLD) leadership, including a call to remove Chairman Mark Patterson and review all alternatives, such as a possible sale, has put governance and future direction in sharp focus for shareholders. See our latest analysis for Americold Realty Trust. The activist spotlight arrives after a tough stretch for investors, with a 1-year total shareholder return of about a 43% decline and a 5-year total shareholder return of about a 64%...

PENN Entertainment has opened the new US$360 million land-based Hollywood Casino Aurora across from Chicago Premium Outlets, nearly doubling its local workforce to about 700 people and preparing to transfer operations from its older riverboat site pending final regulatory approvals and funding support from Gaming and Leisure Properties and the City of Aurora. This expansion deepens PENN’s presence in the competitive Chicagoland casino corridor while highlighting its asset-light funding model...

Alexandria Real Estate Equities, Inc. (NYSE: ARE) was removed from the FTSE All-World Index (USD) on 21 March 2026, potentially affecting how index-tracking funds and other benchmarked investors hold the stock. This index removal highlights how Alexandria’s exposure to passive investment flows can influence trading activity independently of its underlying life science real estate fundamentals. Now, we’ll examine how Alexandria’s removal from the FTSE All-World Index may affect its investment...

Ingles Markets (IMKT.A) is in the middle of a contested proxy fight as Summer Road LLC challenges the board slate and executive pay, just weeks before the April 30, 2026 shareholder meeting. See our latest analysis for Ingles Markets. Recent activism and the latest dividend affirmation are playing out against a strong run in the shares, with a 90 day share price return of 31.01% and a 1 year total shareholder return of 39.58%, suggesting momentum has been building rather than fading. If this...

In March 2026, Celcuity reported that its full-year 2025 net loss widened to US$177.04 million, or US$3.79 per share, while management emphasized the FDA’s earlier acceptance of its gedatolisib New Drug Application with priority review and a July 17, 2026 PDUFA date. The company also indicated it has largely completed building out its sales force and internal systems, underscoring how regulatory progress on gedatolisib is being matched by concrete steps toward commercial readiness. Next,...